TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MIRM

Mirum Pharmaceuticals Inc

Healthcare · Biotechnology

92.00$ +0.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement MIRM
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
5.7% 9.9% 16.1% 25.2% 24.2% 19.3%
-5.7% 90.1% 83.9% 74.8% 75.8% 80.7%
741.9% 686.7% 138.6% 55.1% 41.7% 35.7%
206.3% 261.4% 22.0% 74.9% 56.6% 49.3%
942.5% 996.2% 254.2% 133.3% 101.8% 85.0%
-948.1% -906.1% -170.3% -58.6% -26.0% -4.2%
3.0% 91.9% 20.7% 8.1% 4.2% 2.8%
-938.8% -438.7% -184.4% -87.1% -25.8% -4.1%
0.1% 0.2% -8.3% 0.5% 0.3% 0.4%
-938.8% -438.9% -176.0% -87.7% -26.1% -4.5%
-930.1% -341.7% -159.4% -73.2% -14.5% 3.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?